Provision of Family Planning to Women With Cardiovascular Risk Factors

References

1. 1.↵
   1. Hoyert DL,
   2. Xu J

   . Deaths: preliminary data for 2011. Natl Vital Stat Rep 2012;61:1–51. Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_06.pdf. Accessed November 17, 2014.

   OpenUrlPubMed
2. 2.↵
   1. Ames M,
   2. Rueda J,
   3. Caughey AB

   . Ambulatory management of chronic hypertension in pregnancy. Clin Obstet Gynecol 2012;55:744–55.

   OpenUrlPubMed
3. 3.↵
   1. Mustafa R,
   2. Ahmed S,
   3. Gupta A,
   4. Venuto RC

   . A comprehensive review of hypertension in pregnancy. J Pregnancy 2012;2012:105918.

   OpenUrlPubMed
4. 4.↵
   1. Sibai BM,
   2. Caritis S,
   3. Hauth J,
   4. et al

   . Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000;182:364–9.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Andrade SE

   . Prescription drug use in pregnancy. Am J Obstet Gynecol 2004;191:398–407.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Cooper WO,
   2. Hernandez-Diaz S,
   3. Arbogast PG,
   4. et al

   . Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443–51.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Godfrey LM,
   2. Erramouspe J,
   3. Cleveland KW

   . Teratogenic risk of statins in pregnancy. Ann Pharmacother 2012;46:1419–24.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Guo F,
   2. He D,
   3. Zhang W,
   4. Walton RG

   . Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol 2012;60:599–606.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. McTigue KM,
   2. Garrett JM,
   3. Popkin BM

   . The natural history of the development of obesity in a cohort of young US adults between 1981 and 1998. Ann Intern Med 2002;136:857–64.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    Centers for Disease Control and Prevention. Prevalence of cholesterol screening and high blood cholesterol among adults—United States, 2005, 2007, and 2009. Available from: http://www.cdc.gov.ezproxy.bu.edu/mmwr/preview/mmwrhtml/mm6135a2.htm. Accessed November 17, 2014.
11. 11.↵
    American College of Obstetricians and Gynecologists. ACOG Committee Opinion number 313, September 2005. The importance of preconception care in the continuum of women's health. Obstet Gynecol 2005;106:665–6.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Schwarz EB,
    2. Maselli J,
    3. Gonzales R

    . Contraceptive counseling of diabetic women of reproductive age. Obstet Gynecol 2006;107:1070–4.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Schwarz EB,
    2. Postlethwaite D,
    3. Hung YY,
    4. Lantzman E,
    5. Armstrong MA,
    6. Horberg MA

    . Provision of contraceptive services to women with diabetes mellitus. J Gen Intern Med 2011;27:196–201.

    OpenUrlPubMed
14. 14.↵
    1. Schraudenbach A,
    2. McFall S

    . Contraceptive use and contraception type in women by body mass index category. Womens Health Issues 2009;19:381–9.

    OpenUrlPubMed
15. 15.↵
    1. Moreau C,
    2. Trussell J

    . Results from pooled phase III studies of ulipristal acetate for emergency contraception. Contraception 2012;86:673–80.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Lopez LM,
    2. Grimes DA,
    3. Chen M,
    4. et al

    . Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev 2013;4:CD008452.

    OpenUrlPubMed
17. 17.↵
    1. Finer LB,
    2. Zolna MR

    . Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception 2011;84:478–85.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Curtis KM,
    2. Tepper NK,
    3. Marchbanks PA

    . U.S. medical eligibility criteria for contraceptive use, 2010. J Womens Health 2011;20:825–8.

    OpenUrl
19. 19.↵
    1. Dunlop AL,
    2. Gardiner PM,
    3. Shellhaas CS,
    4. Menard MK,
    5. McDiarmid MA

    . The clinical content of preconception care: the use of medications and supplements among women of reproductive age. Am J Obstet Gynecol 2008;199:S367–72.

    OpenUrlCrossRefPubMed
20. 20.↵
    National Center for health Statistics. Survey content for the National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey. Atlanta (GA): Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/nchs/data/ahcd/body_NAMCSOPD.pdf. Accessed November 17, 2014.
21. 21.↵
    Ambulatory health care data. About the ambulatory health care surveys. Atlanta (GA): Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/nchs/ahcd/about_ahcd.htm. Accessed November 17, 2014.
22. 22.↵
    Ambulatory health care data. Scope and sample design. Atlanta (GA): Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/nchs/ahcd/ahcd_scope.htm#namcs_scope. Accessed November 17, 2014.
23. 23.↵
    Ambulatory health care data. Data collection and processing. Atlanta (GA): Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/nchs/ahcd/ahcd_data_collection.htm#namcs_collection. Accessed November 17, 2014.
24. 24.↵
    National Hospital Ambulatory Medical Care Survey: 2010 summary tables. Available from: http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tables.pdf. Accessed November 17, 2014.
25. 25.↵
    Ambulatory health care data. Reliability of estimates. Atlanta (GA): Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/nchs/ahcd/ahcd_estimation_reliability.htm. Accessed November 17, 2014.
26. 26.↵
    1. Schwarz EB,
    2. Maselli J,
    3. Norton M,
    4. Gonzales R

    . Prescription of teratogenic medications in United States ambulatory practices. Am J Med 2005;118:1240–9.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Perritt JB,
    2. Burke A,
    3. Jamshidli R,
    4. Wang J,
    5. Fox M

    . Contraception counseling, pregnancy intention and contraception use in women with medical problems: an analysis of data from the Maryland Pregnancy Risk Assessment Monitoring System (PRAMS). Contraception 2013;88:263–8.

    OpenUrlPubMed
28. 28.↵
    1. Frost JJ

    . Trends in US women's use of sexual and reproductive health care services, 1995–2002. Am J Public Health 2008;98:1814–7.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Freund KM,
    2. Bird CE

    . Comprehensive healthcare: why is the inclusion of reproductive health controversial for women but not men? Womens Health Issues 2012;22:e347–9.

    OpenUrlPubMed
30. 30.↵
    Preconception health and health care. Medical conditions. Atlanta (GA): Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/preconception/careforwomen/conditions.html. Accessed November 17, 2014.
31. 31.↵
    Institute of Medicine. Clinical preventive services for women: closing the gaps. Washington, DC: National Academy of Sciences; 2011. Available from: http://www.iom.edu/reports/2011/clinical-preventive-services-for-women-closing-the-gaps.aspx. Accessed November 17, 2014.
32. 32.↵
    1. Kocher R,
    2. Emanuel EJ,
    3. DeParle N-AM

    . The Affordable Care Act and the future of clinical medicine: the opportunities and challenges. Ann Intern Med 2010;153:536–9.

    OpenUrlCrossRefPubMedWeb of Science
33. 33.↵
    1. Schwarz EB,
    2. Parisi SM,
    3. Handler SM,
    4. et al

    . Clinical decision support to promote safe prescribing to women of reproductive age: a cluster-randomized trial. J Gen Intern Med 2012;27:831–8.

    OpenUrlCrossRefPubMed
34. 34.↵
    1. Schwarz EB

    . Counseling about medication-induced birth defects with clinical decision support in primary care. J Womens Health 2013;22:817–24.

    OpenUrlCrossRef
35. 35.↵
    1. Schwarz EB,
    2. Parisi SM,
    3. Williams SL,
    4. Shevchik GJ,
    5. Hess R

    . Promoting safe prescribing in primary care with a contraceptive vital sign: a cluster-randomized controlled trial. Ann Fam Med 2012;10:516–22.

    OpenUrlAbstract/FREE Full Text
36. 36.↵
    Summary table of measures, product lines and changes. HEDIS 2013. Vol. 2. Available from: http://www.ncqa.org/Portals/0/HEDISQM/HEDIS2013/List_of_HEDIS_2013_Measures_7.2.12.pdf. Accessed November 17, 2014.
37. 37.↵
    1. Gilchrist VJ,
    2. Stange KC,
    3. Flocke SA,
    4. McCord G,
    5. Bourguet C

    . A comparison of the National Ambulatory Med Care Survey (NAMCS) measurement approach with direct observation of outpatient visits. Med Care 2004;42:276–80.

    OpenUrlCrossRefPubMedWeb of Science
38. 38.↵
    1. Garbers S,
    2. Correa N,
    3. Tobier N,
    4. Blust S,
    5. Chiasson MA

    . Association between symptoms of depression and contraceptive method choices among low-income women at urban reproductive health centers. Matern Child Health J 2010;14:102–9.

    OpenUrlCrossRefPubMedWeb of Science
39. 39.↵
    1. Scott-Ram R,
    2. Chor J,
    3. Bhogireddy V,
    4. Keith L,
    5. Patel A

    . Contraceptive choices of overweight and obese women in a publically funded hospital: possible clinical implications. Contraception 2012;86:122–6.

    OpenUrlPubMed
40. 40.↵
    1. Rocca CH,
    2. Hubbard AE,
    3. Johnson-Hanks J,
    4. Padian NS,
    5. Minnis AM

    . Predictive ability and stability of adolescents' pregnancy intentions in a predominantly Latino community. Stud Fam Plann 2010;41:179.

    OpenUrlCrossRefPubMed
41. 41.↵
    1. Phelan S

    . Pregnancy: a “teachable moment” for weight control and obesity prevention. Am J Obstet Gynecol 2010;202:135.e1–8.

    OpenUrlCrossRefPubMed
42. 42.↵
    1. Moos MK,
    2. Dunlop AL,
    3. Jack BW,
    4. et al

    . Healthier women, healthier reproductive outcomes: recommendations for the routine care of all women of reproductive age. Am J Obstet Gynecol 2008;199:S280–9.

    OpenUrlCrossRefPubMedWeb of Science